Understanding the structure, activity and inhibition of chorismate synthase from Mycobacterium tuberculosis

Current Medicinal Chemistry

Volumn 18, Issue 9, 2011, Pages 1311-1317

  Arcuri, H A ^a,b   Palma, M S ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c National Institute of Science and Technology on Immunology (INCT/ iii)   (Brazil)

Author keywords

Chorismate synthase; Mycobacterium tuberculosis; Shikimate pathway

Indexed keywords

ANTIBIOTIC AGENT; BENZYLIDENE 6,7 DIHYDROXYBENZOFURAN 3[2H]ONE DERIVATIVE; CHORISMATE SYNTHASE; CHORISMATE SYNTHASE INHIBITOR; CHORISMIC ACID; SHIKIMIC ACID; SYNTHETASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BINDING KINETICS; CATALYSIS; DRUG DESIGN; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ENZYME INHIBITORS; FLAVIN MONONUCLEOTIDE; MYCOBACTERIUM TUBERCULOSIS; PHOSPHORUS-OXYGEN LYASES; PROTEIN STRUCTURE, TERTIARY; SHIKIMIC ACID;

EID: 79952806605     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029528     Document Type: Article

References (57)

1. WHO. World Health Organization. Global Tuberculosis Control. Surveillance, Planning, Financing, 2008.
2. Duncan, K. Identification and validation of novel drug targets in tuberculosis. Curr. Pharm. Des, 2004, 10, 3185-3194. (Pubitemid 39276608)
3. Dye, C.; Scheele, S.; Dolin, P.; Pathania, V.; Raviglione, M.C. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. JAMA, 1999, 282, 677-686. (Pubitemid 29384157)
4. Bloom, B.R.; Murray, C.J.L. Tuberculosis: Commentary on a reemergent killer. Science, 1998, 257, 1055-1064.
5. Migliori, G.B.; Richardson, M.D'Arcy; Sotgiu, G.; Lange, C. Multidrugresistant and extensively drug-resistant tuberculosis in the west europe and united states: Epidemiology, surveillance, and control. Clin. Chest Med.,2009, 30, 637-665.
6. Pablos-Mendez, A.; Gowda, D.K.; Frieden, T. Controlling multidrugresistant tuberculosis and access to expensive drugs: A rational framework. Bull. World Health Organ., 2002, 80, 489-500.
7. CDC (Centers for Disease Control and Prevention). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugsworldwide, 2000-2004. Morb. Mortal. Wkly. Rep., 2006, 55, 301-305.
8. Segura-Cabrera, A.; Rodríguez-Pérez, M.A. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening. Bioorg. Med. Chem. Lett., 2008, 18(11), 3152-3157. (Pubitemid 351721011)
9. Parish, T.; Stoker, N.G. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology, 2002, 148(10), 3069-3077. (Pubitemid 35243706)
10. Roberts, F.; Roberts, C.W.; Johnson, J.J.; Kylell, D.E.; Krell, T.; Coggins, J.R.; Coombs, G.H.; Milhous, W.K.; Triphuri, S.; Ferguson, D.J.P.; Chakrabarti, D.; McLeod, R. Evidence for the shikimate pathway in apicomplexan parasites. Nature, 1998, 393, 801-805. (Pubitemid 28299493)
11. Bentley, R. The shikimate pathway- metabolic tree with many branches. Crit. Rev. Biochem. Mol. Biol., 1990, 25, 307-384. (Pubitemid 120012279)
12. Pittard, A.J. In: Escherichia coli and Salmonella typhimurium: Cellular and molecular biology; Neidhardt, F.C.; Ingraham, J.L.; Low, K.B.; Magasanik, B.; Schaechter, M.; Umbarger, H.E., Eds.; American Society for Microbiology: Washington, 1987, pp. 368-394.
13. Haslam, E. Shikimic acid: Metabolism and metabolites. Wiley & Sons: Chichester, 1993.
14. Herrmann K.M. The shikimate pathway: Early steps in the biosynthesis of aromatic compounds. Plant Cell, 1995, 7, 907-919.
15. Roberts, C.W.; Roberts, F; Lyons, R.E.; Kirisits, M.J.; Mui, E.J.; Finnerty, J.; Johnson, J.J.; Ferguson, D.J.P.; Coggins, J.R.; Krell, T.; Coombs, G.H.; Milhous, W.K.; Kyle, D.E.; Tzipori, S.; Barnwell, J.; Dame, J.B.; Carlton, J.; McLeod, R. The shikimate pathway and its branches in apicomplexan parasites. J. Infect. Dis., 2002, 185(S1), S25-S36. (Pubitemid 34142826)
16. Davies, G.M.; Barret-Bee, K.J.; Jude, D.A.; Lehan, M.; Nichols, W.W.; Pinder, P.E.; Thain, J.L.; Watkins, W.J.; Wilson, R.G. (6S)-6-fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrob. Agents Chemother., 1994, 38, 403-406. (Pubitemid 24054276)
17. Coggins, J.R. In: Herbicides and Plant Metabolism; Dodge, A., Ed.; Cambridge University Press: Cambridge, 1989, pp. 97-112.
18. Coggins, J.R.; Duncan, K.; Anton, I.A.; Boocock, M.R.; Chaudhuri, S.; Lambert, J.M.; Lewendon, A.; Millar, G.; Mousdale, D.M.; Smith, D.D. The anatomy of a multifunctional enzyme. Biochem. Soc. Trans., 1987, 15, 754-759.
19. Mousdale, D.M.; Campbell, M.S.; Coggins, J.R. Purification and characterisation of a bifunctional dehydroquinase-shikimate: NADP oxidoreductase from peas seedlings. Phytochemistry, 1987, 26, 2665-2670.
20. Campbell, S.A.; Richards, T.A.; Mui, E.J.; Samuel, B.U.; Coggins, J.R.; McLeod, R.; Roberts, C.W. A complete shikimate pathway in Toxoplasma gondii: An ancient eukaryotic innovation. Int. J. Parasitol., 2004, 34, 5-13. (Pubitemid 38056609)
21. Duncan, K.; Edwards, R.M.; Coggins, J.R. The pentafunctional arom enzyme of Saccharomyces cerevisiae is a mosaic of monofunctional domains. Biochem. J., 1987, 246, 375-386.
22. Herrmann, K.M.; Weaver, L.M. The shikimate pathway. Annu. Rev. Plant Physiol. Mol. Biol., 1999, 50, 473-503. (Pubitemid 129491971)
23. Coggins, J.R.; Abell, C.; Evans, L.B.; Frederickson, M.; Robinson, D.A.; Roszak, A.W.; Lapthorn, A.P. Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochem. Soc. Trans., 2003, 31, 548-551.
24. Ramjee, M.K.; Balasubramanian, S.; Abell, C.; Coggins, J.R.; Davies, G.M.; Hawkes, T.R.; Lowe, D.J.; Thorneley, R.N.F. Reaction of (6R)-6-F-EPSP with recombinant Escherichia coli chorismate synthase generates a stable flavin mononucleotide semiquinone radical. J. Am. Chem. Soc., 1992, 114, 3151-3153.
25. Maddry, J.A.; Ananthan, S.; Goldman, R.C.; Hobrath, J.V.; Kwong, C.D.; Maddox, C.; Rasmussen, L.; Reynolds, R.C.; Secrist III, J.A.; Sosa, M.I.; White, E.L.; Zhang, W. Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis, 2009, 89, 354-363.
26. Ducati, R.G.; Basso, L.A.; Santos, D.S. Mycobacterial shikimate pathway enzymes as targets for drug design. Curr. Drug Targets, 2007, 8, 423-435. (Pubitemid 46381293)
27. Viola, C.M.; Saridakis, V.; Christendat, D. Crystal structure of chorismate synthase from Aquifex aeolicus reveals a novel beta alpha beta sandwich topology. Proteins, 2004, 54(1), 166-169. (Pubitemid 38036925)
28. Maclean, J.; Ali, S. The structure of chorismate synthase reveals a novel flavin binding site fundamental to a unique chemical reaction. Structure, 2003, 11(12), 1499-1511. (Pubitemid 37510349)
29. Quevillon-Cheruel, S.; Leulliot, N.; Meyer, P.; Graille, M.; Bremang, M.; Blondeau, K.; Sorel, I.; Poupon, A.; Janin, J.; van Tilbeurgh, H. Crystal structure of the bifunctional chorismate synthase from Saccharomyces cerevisiae. J. Biol. Chem., 2004, 279(1), 619-625. (Pubitemid 38044866)
30. Ahn, H.J.; Yoon, H.J.; Lee, B.; Suh, S.W. Crystal structure of chorismate synthase: A novel FMN-binding protein fold and functional insights. J. Mol. Biol., 2004, 336(4), 903-915. (Pubitemid 38201539)
31. Dias, M.V.; Borges, J.C.; Ely, F.; Pereira, J.H.; Canduri, F.; Ramos, C.H.; Frazzon, J.; Palma, M.S.; Basso, L.A.; Santos, D.S.; de Azevedo Jr., W.F. Structure of chorismate synthase from Mycobacterium tuberculosis. J. Struct. Biol., 2006, 154(2), 130-43. (Pubitemid 44316757)
32. Dias, M.V.; Ely, F.; Canduri, F.; Pereira, J.H.; Frazzon, J.; Basso, L.A.; Palma, M.S.; de Azevedo Jr., W.F.; Santos, D.S. Crystallization and preliminary X-ray crystallographic analysis of chorismate synthase from Mycobacterium tuberculosis. Acta Crystallogr. D Biol. Crystallogr., 2004, 60(11), 2003-2005. (Pubitemid 41087532)
33. Rauch, G.; Ehammer, H.; Bornemann, S.; Macheroux, P. Mutagenic analysis of an invariant aspartate residue in chorismate synthase supports its role as an active site base. Biochemistry, 2007, 46, 3768-3774. (Pubitemid 46493476)
34. Ehammer, H.; Rauch, G.; Prem, A.; Kappes, B.; Macheroux, P. Conservation of NADPH utilization by chorismate synthase and its implications for the evolution of the shikimate pathway. Mol. Microbiol., 2007, 65(5), 1249-1257. (Pubitemid 47262823)
35. Ely, F.; Nunes, J.E.S.; Schroeder, E.K.; Frazzon, J.; Palma, M.S.; Santos, D.S.; Basso, L.A. The Mycobacterium tuberculosis Rv2540c DNA sequence encodes a bifunctional chorismate synthase. BMC Biochem., 2008, 9, 13.
36. Macheroux, P.; Schmid, J.; Amrhein, N.; Schaller, A. A unique reaction in a common pathway: Mechanism and function of chorismate synthase in the shikimate pathway. Planta, 1999, 207, 325-334. (Pubitemid 29055407)
37. Kitzing. K.; Macheroux, P.; Amrhein, N. Spectroscopic and kinetic characterization of the bifunctional chorismate synthase from Neurospora crassa: Evidence for a common binding site for 5-enolpyruvylshikimate 3-phosphate and NADPH. J. Biol. Chem., 2001, 276(46), 42658-42666.
38. Macheroux P.; Schonbrunn, E.; Svergun, D.I.; Volkov, V.V.; Koch, M.H.; Bornemann, S.; Thorneley, R.N. Evidence for a major structural change in Escherichia coli chorismate synthase induced by flavin and substrate Binding. Biochem. J., 1998, 335, 319-327. (Pubitemid 28491066)
39. Dias, M.V.D.; Ely, F.; Palma, M.S.; de Azevedo Jr., W.F.; Basso, L.A.; Santos, D.S. Chorismate synthase: An attractive target for drug development against orphan diseases. Curr. Drug Targets, 2007, 8, 437-444. (Pubitemid 46381294)
40. Henstrand, J. M.; Amrhein, N.; Schmid, J. Cloning and characterization of a heterologously expressed bifunctional chorismate synthase/flavin reductase from Neurospora crassa. J. Biol. Chem., 1995, 270(35), 20447-20452.
41. Hasan, N.; Nester, E.W. Purification and properties of chorismate synthase from Bacillus subtilis. J. Biol. Chem., 1978, 253, 4993-4998. (Pubitemid 8382170)
42. Holm, L.; Kaariainen, S.; Rosenstrom, P.; Schenkel A. Searching protein structure databases with DaliLite v.3. Bioinformatics, 2008, 24, 2780-2781. (Pubitemid 352722625)
43. Arcuri, H.A.; Zafalon, G.F.; Marucci, E.A.; Bonalumi, C.E.; da Silveira, N.J.; Machado, J.M.; de Azevedo, W.F. Jr.; Palma, M.S. SKPDB: A structural database of shikimate pathway enzymes. BMC Bioinformatics, 2010, 11, 12.
44. Collaborative Computational Project. The CCP4 Suite: Programs for Protein Crystallography. Acta Cryst., 1994, 4 (D50), 760-763.
45. Shindyalov, I.N.; Bourne, P.E. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Prot. Eng., 1998, 11(9), 739-747. (Pubitemid 28434482)
46. Floss, H.G.; Onderka, D.K.; Carroll, M. Stereochemistry of the 3-deoxy-Darabino- heptulosonate 7-phosphate synthetase reaction and the chorismate synthetase reaction. J. Biol. Chem., 1972, 247, 736-744.
47. Morell, H.; Clark, M.J.; Knowles, P.F.; Sprinson, D.B. The enzymic synthesis of chorismic and prephenic acids from 3-enolpyruvylshikimic acid 5- phosphate. J. Biol. Chem., 1967, 242, 82-90.
48. Hill, R.K.; Bock, M.G. Stereochemistry of 1,4-conjugate elimination reactions. J. Am. Chem. Soc., 1979, 100, 37-639.
49. Fukui, K. Stereoselectivity associated with noncycloaddition to unsaturated bonds. Tetrahedron Lett., 1965, 2427-2432.
50. Ganem, B. From glucose to aromatics: Recent developments in natural products of the shikimic acid pathway. Tetrahedron, 1978, 34, 3353-3383.
51. Bartlett, P.A.; Maitra, U.; Chouinard, P.M. Synthesis of 'iso-EPSP' and evaluation of its interaction with chorismate synthase. J. Am. Chem. Soc., 1986, 108, 8068-8071.
52. Macheroux, P.; Bornemann, S.; Thorneley, R.N.F. In: Flavins and Flavoproteins 1996; Stevenson, K.J.; Massey, V.; Williams, C.H.J., Eds.; University of Calgary Press: Canada, 1997, pp. 113-122.
53. White, P.J.; Millar, G.; Coggins, J.R. The overexpression, purfication and complete amino acid sequence of chorismate synthase from Escherichia coli K12 and its comparison with the enzyme from Neurospora crassa. Biochem. J., 1988, 251, 313-322.
54. Thomas, M.G.; Lawson, C.; Allanson, N.M.; Leslie, B.W.; Bottomley, J.R.; Andrew McBride, A.; Olusanya, O.A. A series of 2(Z)-2-benzylidene-6,7- dihydroxybenzofuran-3 [2H]-ones as inhibitors of chorismate synthase. Bioorg. Med. Chem. Lett., 2003, 13, 423-426. (Pubitemid 36259706)
55. Pongdee, R.; Liu, H.W. Elucidation of enzyme mechanisms using fluorinated substrate analogues. Bioorg. Chem., 2004, 32, 393-437. (Pubitemid 39294572)
56. de Azevedo Jr, W.F.; Caceres, R.A; Pauli, I.; Timmers, L.F.S.M.; Barcellos, G.B.; Rocha, K.B.; Soares, M.B.P. Protein-drug interaction studies for development of drugs against Plasmodium falciparum. Curr. Med. Chem., 2009, 10, 271-278
57. Afshar, C.; Jaffe, E.K.; Carrell, H.L.; Markham, G.D.; Rajagopalan, J.S.; Rossi, M.; Glusker, J.P. The molecular conformation of chorismic acid in the crystalline state. Bioorg. Chem., 1992, 20, 323-333.